Four biotechnology companies are going public Friday, led by PMV Pharmaceuticals, which just increased the size of its deal.
PMV could raise as much as $211.8 million when it prices its deal later Thursday. Earlier, the company boosted the size of its offering and is now selling 11.765 million shares, up from 7.35 million shares, according to a regulatory filing dated Sept. 24. The price range remained $16 to $18 each.
PMV is expected to trade Friday on the Nasdaq market under the ticker PMVP. Underwriters on the deal include Goldman Sachs, Bank of America Securities, Cowen and Evercore ISI.